Vaxcyte Inc. buy BiotechBee
Start price
25.10.22
/
80%
€33.40
Target price
31.12.24
€45.00
Performance (%)
32.93%
End price
05.05.23
€44.40
Summary
This prediction ended on 05.05.23 with a price of €44.40. With a performance of 32.93% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Vaxcyte Inc. where he still thinks Vaxcyte Inc. is a Buy. BiotechBee has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Vaxcyte Inc. | 7.080% | 7.080% | 35.045% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to BiotechBee what are the pros and cons of Vaxcyte Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Vaxcyte Inc. diskutieren
Buy mit Kursziel 45,0
In the thread Trading Vaxcyte Inc.
Buy beendet
Current prediction by BiotechBee for Vaxcyte Inc.
Vaxcyte Inc.
Start price
Target price
Perf. (%)
€49.20
24.06.23
24.06.23
€70.00
31.12.26
31.12.26
20.94%
02.05.24
02.05.24
Could be very worthwhile Investment >20% year